AI-Guided Functional Genomics: From CRISPR Screens to Causal Target Commitment

Oct 28, 2026
Discovery Biology

• Examine how AI analyzes large-scale CRISPR and Perturb-seq screens to distinguish causal drivers from correlative signals.

• Using AI-based modeling to infer causal targets and target combinations with translational relevance
• Explore how combinatorial perturbation modelling uncovers context-specific dependencies and synthetic lethal interactions.
• Assess how intervention-driven evidence improves target prioritization and increases confidence before advancing into chemistry.

Speakers
Wen-Han Yu
Wen-Han Yu, Director, Therapeutics & Translational Bioinformatics - Moderna